Compound ID | 1331
Class: Quinazoline
| Spectrum of activity: | Gram-negative |
| Institute where first reported: | Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, Florida, USA Center for Drug Discovery and Innovation, University of South Florida, Tampa, Florida, USA |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://aac.asm.org/content/61/6/e00059-17 |